Nationally, COVID-19 ED visits grew by 23.5% as of July 6, compared to the week prior. The CDC defines a “substantial increase” as a growth of 20% or more.
Mississippi saw the largest increase of 82.9% of visits diagnosed as COVID-19 from last week compared to the week prior, CDC data shows.
The other states seeing the largest increase in COVID-19 ED diagnoses over the same time frame are:
- Rhode Island — 55.1%
- Idaho — 51.5%
- Iowa — 44.6%
- Michigan — 41%
- South Carolina — 38.8%
- Texas — 37.5%
- Louisiana — 36.3%
- Indiana — 35.9%
- Georgia — 35.8%
- Maryland — 35.4%
- Connecticut — 34.5%
- Kentucky — 33.7%
- Illinois — 33.5%
- Virginia — 33.1%
- Montana — 32.7%
- New Hampshire — 31.7%
- Ohio — 30.5%
- Utah — 28.4%
- Wisconsin — 27.9%
- Florida — 27.9%
- Massachusetts — 26.7%
- Arkansas — 26.1%
- Tennessee — 22.7%
- Pennsylvania — 22%
- Kansas — 21.1%
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
